Cargando…

Integrated analysis of competitive endogenous RNA networks in elder patients with non-small cell lung cancer

Lung cancer is one of the most prevalent cancers and the leading cause of cancer-related deaths worldwide; non-small cell lung cancer (NSCLC) comprises approximately 80% of all lung cancer cases. This study aimed to construct a competing endogenous RNA (ceRNA) network and identify prognostic signatu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zi, Yu, Fei, Zhu, Bei, Li, Qin, Yu, Yue, Zong, Feng, Liu, Wen, Zhang, Mingjiong, Wu, Shuangshuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997791/ https://www.ncbi.nlm.nih.gov/pubmed/36897674 http://dx.doi.org/10.1097/MD.0000000000033192

Ejemplares similares

Construction and comprehensive analysis of a competitive endogenous RNA network to reveal potential biomarkers for the malignant differentiation of glioma
por: Li, Xin, et al.
Publicado: (2021)

The mechanism of Bai He Gu Jin Tang against non-small cell lung cancer revealed by network pharmacology and molecular docking
por: Xie, Rui-fei, et al.
Publicado: (2022)

Pulmonary function protection by single-port thoracoscopic segmental lung resection in elderly patients with IA non-small cell lung cancer: A differential matched analysis
por: Wang, Silin, et al.
Publicado: (2023)

Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Taxus chinensis against non-small cell lung cancer
por: Zhang, Shujuan, et al.
Publicado: (2023)

Enteral administration of alectinib for ALK-positive non-small cell lung cancer in an elderly patient: A case report
por: Thomas, Quentin Dominique, et al.
Publicado: (2021)

A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly
por: Wang, Peng, et al.
Publicado: (2016)

Correlation of microRNA-335 expression level with clinical significance and prognosis in non-small cell lung cancer
por: Huo, Wen, et al.
Publicado: (2020)

(18)F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer
por: Guan, Jian, et al.
Publicado: (2016)

Small cell lung cancer treated by radiofrequency ablation: A case report
por: Song, Guo-qiang, et al.
Publicado: (2017)

Concurrent Oncogene Mutation Profile in Chinese Patients With Stage Ib Lung Adenocarcinoma
por: Wen, Ying-Sheng, et al.
Publicado: (2014)

Construction of competing endogenous RNA network and identification of novel molecular biomarkers in colon cancer: A bioinformatic analysis
por: Xi, Gu, et al.
Publicado: (2021)

Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer
por: Li, Fanghua, et al.
Publicado: (2023)

Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomics
por: Geng, Xue, et al.
Publicado: (2023)

Integrated analysis of ceRNA network in hepatocellular carcinoma using bioinformatics analysis
por: Luo, Yu, et al.
Publicado: (2021)

A Bayesian network analysis of immunotherapy and taxane chemotherapy as second- or later-line treatments in non-small cell lung cancer
por: Liu, Xin-Xiu, et al.
Publicado: (2022)

Temozolomide plus whole brain radiotherapy for the treatment of non-small-cell lung cancer patients with brain metastases: A protocol of an updated systematic review and meta-analysis
por: Duan, Hua, et al.
Publicado: (2020)

Predictors for survival in patients with bone metastasis of small cell lung cancer: A population-based study
por: Xue, MingFeng, et al.
Publicado: (2021)

Comparison between atlas and convolutional neural network based automatic segmentation of multiple organs at risk in non-small cell lung cancer
por: Zhang, Tao, et al.
Publicado: (2020)

Responses to crizotinib and cabozantinib in patient with lung adenocarcinoma harboring mesenchymal-epithelial transition factor exon 14 skipping mutation: A case report
por: Qin, Ruo-Yan, et al.
Publicado: (2021)

Expression of miR-92a is associated with the prognosis in non-small cell lung cancer: An observation study
por: Huang, Yu-Fang, et al.
Publicado: (2022)

Small-Cell Lung Cancer Transformation in Patients With Pulmonary Adenocarcinoma: A Case Report and Review of Literature
por: Jiang, Shi-Yu, et al.
Publicado: (2016)

Plasma angiopoietin-2 is persistently elevated after non-small cell lung cancer surgery and stimulates angiogenesis in vitro
por: Zhou, Leng, et al.
Publicado: (2016)

An elderly advanced non-small cell lung cancer patient harboring rare epidermal growth factor receptor mutations L861R benefited from afatinib: A case report
por: Qu, Fanjie, et al.
Publicado: (2021)

Platinum versus immunotherapy for early resectable non-small cell lung cancer: A protocol for systematic review and meta analysis
por: Tong, Zhangwei, et al.
Publicado: (2020)

Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer
por: Wu, Ching-Feng, et al.
Publicado: (2015)

Definitive local therapy for extracranial single-organ oligorecurrent non-small-cell lung cancer: A single institutional retrospective study
por: Jin, Jia-Nan, et al.
Publicado: (2022)

Serum levels of retinol-binding protein 4 and the risk of non-small cell lung cancer: A case-control study
por: Hu, Xiaoping, et al.
Publicado: (2020)

Co-alteration of EGFR mutation and ALK rearrangement in non-small cell lung cancer: Case series
por: Shin, Hong-Joon, et al.
Publicado: (2019)

Gefitinib provides similar effectiveness and improved safety than erlotinib for advanced non-small cell lung cancer: A meta-analysis
por: Zhang, Wenxiong, et al.
Publicado: (2018)

Complete response of radioresistant brain metastases from non-small cell lung cancer with temozolomide: A case report and literature review
por: Yang, Yi, et al.
Publicado: (2020)

MicroRNA Expression Profile Reveals miR-17-92 and miR-143-145 Cluster in Synchronous Colorectal Cancer
por: Meng, Wen-Jian, et al.
Publicado: (2015)

The Risk of Neutropenia and Leukopenia in Advanced Non-Small Cell Lung Cancer Patients Treated With Erlotinib: A Prisma-Compliant Systematic Review and Meta-Analysis
por: Zhou, Jian-Guo, et al.
Publicado: (2015)

Network module function enrichment analysis of lung squamous cell carcinoma and lung adenocarcinoma
por: Li, Piaopiao, et al.
Publicado: (2022)

Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy
por: Kim, Se Hyun, et al.
Publicado: (2017)

Lentinan combined with cisplatin for the treatment of non-small cell lung cancer
por: Zhao, Chenchen, et al.
Publicado: (2021)

Efficacy and safety of cinobufacini injection combined with vinorelbine and cisplatin regimen chemotherapy for stage III/IV non-small cell lung cancer: A protocol for systematic review and meta-analysis of randomized controlled trials
por: Li, Qian, et al.
Publicado: (2020)

Angiogenesis inhibitors for the treatment of small cell lung cancer (SCLC): A meta-analysis of 7 randomized controlled trials
por: Li, Qing, et al.
Publicado: (2017)

Is surgery indicated for elderly patients with early stage nonsmall cell lung cancer, in the era of stereotactic body radiotherapy?
por: Nguyen, Nam P., et al.
Publicado: (2016)

Vein-first vs artery-first surgical technique for lobectomy of non-small cell lung cancer: A protocol for systematic review and meta-analysis
por: Gao, Lei, et al.
Publicado: (2020)

Upregulation of tissue long noncoding RNA X inactive specific transcript predicts poor postoperative survival in patients with non-small cell lung cancer
por: Fang, Hengxiao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4qls1bqlnh9g9r9ifkh0m6nr4g